Working… Menu

The Addition of Chloroquine to Chemoradiation for Glioblastoma,

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02432417
Recruitment Status : Not yet recruiting
First Posted : May 4, 2015
Last Update Posted : August 14, 2020
Information provided by (Responsible Party):
Maastricht Radiation Oncology